Cargando…
A 3-gene biomarker signature to predict response to taxane-based neoadjuvant chemotherapy in breast cancer
Breast cancer is the most common cancer in women worldwide, affecting one in eight women in their lifetime. Taxane-based chemotherapy is routinely used in the treatment of breast cancer. The purpose of this study was to develop and validate a predictive biomarker to improve the benefit/risk ratio fo...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083332/ https://www.ncbi.nlm.nih.gov/pubmed/32196521 http://dx.doi.org/10.1371/journal.pone.0230313 |